Stay updated with breaking news from Twist Bioscience Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Twist Bioscience Co. (NASDAQ:TWST – Get Free Report) has earned a consensus rating of “Buy” from the six research firms that are covering the firm, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy rating. The average 12 month price objective among brokerages that have covered the stock in the last […]
Dimensional Fund Advisors LP increased its stake in shares of Twist Bioscience Co. (NASDAQ:TWST – Free Report) by 29.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,267,708 shares of the company’s stock after acquiring an additional 284,884 shares […]
Artisan Partners Limited Partnership raised its holdings in Twist Bioscience Co. (NASDAQ:TWST – Free Report) by 111.3% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 3,723,305 shares of the company’s stock after acquiring an additional 1,961,621 shares during the period. Artisan Partners Limited Partnership owned 0.06% of Twist Bioscience worth $137,241,000 as of […]
Twist Bioscience Co. (NASDAQ:TWST – Get Free Report) COO Patrick John Finn sold 2,174 shares of the firm’s stock in a transaction that occurred on Tuesday, April 23rd. The shares were sold at an average price of $30.12, for a total value of $65,480.88. Following the sale, the chief operating officer now owns 176,206 shares […]
Twist Bioscience Co. (NASDAQ:TWST – Get Free Report) COO Patrick John Finn sold 2,174 shares of the business’s stock in a transaction dated Tuesday, April 23rd. The shares were sold at an average price of $30.12, for a total transaction of $65,480.88. Following the completion of the sale, the chief operating officer now directly owns […]